


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
NVS
Novartis AG
$150.45

Login to see Novartis AG (NVS) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow

Outperform the market
Risk Analysis

Investors losing their confidence
Technical Indicators

3+ Days Up
NVS Price Performance
$145.37 (+3.49%)
$166.85 (-9.83%)
$139.18 (+8.10%)
$117.79 (+27.73%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Reported a weak earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to grow
Outperform the market
NVS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
NVS Street Sentiment is bullish and have positive views on the near-term outlook
NVS has Low risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Dec 16, 2025
Reiterate
Neutral
Guggenheim
Dec 10, 2025
Upgrade
Overweight
JP Morgan
Dec 09, 2025
Upgrade
Overweight
JP Morgan
SNY
Sanofi
44.67
+2.57%
ARWR
Arrowhead Pharmaceuticals
77.14
+5.41%
WVE
Wave Life Sciences
6.19
+0.81%
BIOA
BioAge Labs Inc.
16.11
-1.59%
EBS
Emergent Biosolution
8.15
+1.12%
What is NVS current stock price?
What is NVS current Stock IQ?
What is NVS RSI signal right now?
What is NVS analyst price target and upside potential?
What do analysts say about NVS stock?
What is NVS momentum trend right now?
What are NVS stock strengths?
What is NVS Risk Level?
Should I buy NVS stock right now?
Is NVS a Strong Buy right now?
What is NVS market cap and volume?
What factors influence NVS's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
NVS
Novartis AG
Current Price
$150.45
SNY
Sanofi
44.67
+2.57%
ARWR
Arrowhead Pharmaceuticals
77.14
+5.41%
WVE
Wave Life Sciences
6.19
+0.81%
BIOA
BioAge Labs Inc.
16.11
-1.59%
EBS
Emergent Biosolution
8.15
+1.12%

NVS Price Performance
$145.37 (+3.49%)
$166.85 (-9.83%)
$139.18 (+8.10%)
$117.79 (+27.73%)
NVS Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Reported a weak earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to grow
Outperform the market
NVS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
NVS Street Sentiment is bullish and have positive views on the near-term outlook
NVS has Low risk level

Overall Wall Street Rating
NVS Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Outperform the market
Risk Analysis

Investors losing their confidence
Technical Indicators

3+ Days Up
NVS Trading Signals
NVS crossed its MA. Price: $150.45, MA20: $148.63, MA50: $152.36.
NVS has closed up for 3 consecutive days
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.